Although limited to ovarian cancer TILs and healthy primary human T cells, our in vitro evaluations confirmed GPR56-expression and several accompanied co-stimulatory/activation markers on these cell populations. The gene discussed is ADGRG1; the disease is ovarian carcinoma.